Deepaneeta Sarmah

Employment

Employment history is unavailable.

Education

• National Institute of Pharmaceutical Education and Research Ahmedabad PhD
  2016 - 2022
• Indian Institute of Technology BHU Varanasi M. Pharm.
  2014 - 2016
• Delhi Institute of Pharmaceutical Sciences and Research B. Pharm.
  2010 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (28)

• Pyruvate kinase M2 in chronic inflammations: a potpourri of crucial protein-protein interactions.
  Cell biology and toxicology 2021 DOI: 10.1007/s10565-021-09605-0
  +Save
• Post-stroke depression: Chaos to exposition.
  Brain research bulletin 2020 DOI: 10.1016/j.brainresbull.2020.12.012
  +Save
• Nanotechnology in the diagnosis and treatment of stroke.
  Drug discovery today 2020 DOI: 10.1016/j.drudis.2020.11.018
  +Save
• Cerebro-renal interaction and stroke.
  The European journal of neuroscience 2020 DOI: 10.1111/ejn.14983
  +Save
• Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases.
  Immunology 2020 DOI: 10.1111/imm.13264
  +Save
• Migraine and Ischemic Stroke: Deciphering the Bidirectional Pathway.
  ACS chemical neuroscience 2020 DOI: 10.1021/acschemneuro.0c00137
  +Save
• The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India.
  Annals of the New York Academy of Sciences 2020 DOI: 10.1111/nyas.14379
  +Save
• Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy.
  Translational stroke research 2020 DOI: 10.1007/s12975-020-00806-z
  +Save
• Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls.
  ACS pharmacology & translational science 2020 DOI: 10.1021/acsptsci.9b00104
  +Save
• Advances in Studies on Stroke-Induced Secondary Neurodegeneration (SND) and Its Treatment.
  Current topics in medicinal chemistry 2020 DOI: 10.2174/1568026620666200416090820
  +Save